Related Experiment Video
Updated: May 20, 2026
09:31
Touchscreen Sustained Attention Task (SAT) for Rats
Published on: September 15, 2017
Leveraging the cortical cholinergic system to enhance attention
1Psychiatry Department, 4250 Plymouth Road, University of Michigan, Ann Arbor, MI 48109-5765, USA. emd7@duke.edu
Neuropharmacology
|July 17, 2012
Summary
Cognitive enhancers targeting the brain's acetylcholine system show promise for improving attention. Specifically, stimulating nicotinic receptors enhances cue detection, while increasing acetylcholine levels aids attentional control in neurological disorders.
Area of Science:
- Neuroscience
- Pharmacology
- Cognitive Science
Background:
- Attentional impairments are common in neurodegenerative and neuropsychiatric disorders.
- Developing effective cognitive enhancers is challenging due to incomplete understanding of attention circuitry.
- The cortical cholinergic system plays a crucial role in attention.
Purpose of the Study:
- To discuss the role of the cortical cholinergic system in attention.
- To propose novel mechanisms for cognitive enhancers targeting attentional functions.
- To identify specific targets for enhancing cue detection and attentional control.
Main Methods:
- Review and discussion of existing literature on the cortical cholinergic system and attention.
- Hypothesizing specific molecular and circuit-level targets for cognitive enhancement.
- Focus on nicotinic acetylcholine receptors (nAChR) and tonic acetylcholine levels.
Main Results:
- Stimulation of prefrontal α4β2* nicotinic acetylcholine receptors (nAChR) is proposed to enhance cue detection.
- Augmentation of tonic acetylcholine levels is proposed to improve attentional control.
- These mechanisms offer potential pathways for developing targeted cognitive enhancers.
Conclusions:
- The cortical cholinergic system provides viable targets for cognitive enhancement strategies.
- Targeting specific nicotinic acetylcholine receptors and acetylcholine levels can address attentional deficits.
- Further research into these mechanisms could lead to novel treatments for cognitive impairments.
Related Concept Videos
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
01:31Direct-Acting Cholinergic Agonists: Pharmacokinetics
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.
01:22Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
00:59Direct-Acting Cholinergic Agonists: Pharmacological Actions
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...